Dan Leonard, president and CEO of the Association for Accessible Medicines (AAM) since August 2020, outlines his key agenda priorities as head of the USA's largest generic industry body, how the COVID-19 pandemic has altered the discussion around generics and essential medicines, and his hopes for the Biden administration
AAM’s policies are consistent with this administration's agenda. We have already had good conversations with the Biden transition team, even before he was sworn in as president. There was a strong appreciation for the role that generics and biosimilars play, and we look forward to working with them
